# Healthcare Global Enterprises Limited (HCG)

> HCG closed at ₹585.00 on 30 Oct 2026, trailing P/E 383.4, market cap ₹8,734 cr, latest results for the quarter ended 30 Jun 2026. Revenue, profit, ROE, debt, own P/E range and sector-peer comparison from the SEBI filing.

Healthcare Global Enterprises Limited (NSE: HCG) closed at ₹585.00 on 30 Oct 2026, -20.3% over one year, against a 52-week range of ₹513.30 – ₹804.65.

In the quarter ended 30 Jun 2026 (consolidated, filed 6 Aug 2026) it reported revenue of ₹695 cr and net profit of ₹14 cr, a 2.0% net margin; revenue grew 13.4% and profit grew 114.4% year on year.

On four consecutive filed quarters its trailing P/E is 383.4; since 26 May 2025 its own P/E has ranged from 165.7 to 707.6 (median 352.9), and today's reading is higher than 51% of those 354 trading days.

From the balance sheet dated 31 Mar 2026: return on equity 4.1%, ROCE 8.7%, debt-to-equity 0.68, Piotroski F-score 7 of 9.

Against 65 Healthcare peers on NSE: Net margin higher than 6% of 63 sector peers; PBT margin higher than 6% of 63 sector peers; ROE higher than 13% of 63 sector peers.

## Key figures

| Figure | Value |
|---|---|
| Last close | ₹585.00 (30 Oct 2026) |
| Change 1 month / 6 months / 1 year | -16.6% / +2.7% / -20.3% |
| 52-week low – high | ₹513.30 – ₹804.65 |
| Market capitalisation | ₹8,734 cr |
| Trailing P/E | 383.4 |
| Price / book | 6.56 |
| EV / EBITDA | 19.6 |
| Earnings yield | 0.3% |
| TTM EPS | ₹1.53 |
| TTM net profit | ₹23 cr |
| Quarter revenue | ₹695 cr |
| Quarter net profit | ₹14 cr |
| Net margin | 2.0% |
| Revenue growth (YoY) | +13.4% |
| Profit growth (YoY) | +114.4% |
| Return on equity | 4.1% |
| ROCE | 8.7% |
| Debt / equity | 0.68 |
| Current ratio | 1.09 |
| Free cash flow | ₹55 cr |
| Piotroski F-score | 7 / 9 |
| Average daily turnover (50 days) | ₹6.8 cr |

## Questions

### What is the P/E ratio of Healthcare Global Enterprises Limited?

Healthcare Global Enterprises Limited's trailing P/E is 383.4, using the close of 30 Oct 2026 and earnings over the four filed quarters to 30 Jun 2026. Since 26 May 2025 its P/E has ranged 165.7–707.6.

### What were Healthcare Global Enterprises Limited's latest quarterly results?

For the quarter ended 30 Jun 2026, Healthcare Global Enterprises Limited reported revenue of ₹695 cr and net profit of ₹14 cr (consolidated), filed with the exchange on 6 Aug 2026.

### What is Healthcare Global Enterprises Limited's ROE?

Return on equity is 4.1% based on the balance sheet dated 31 Mar 2026.

### Does Healthcare Global Enterprises Limited have debt?

Debt-to-equity is 0.68 on the balance sheet dated 31 Mar 2026.

### What is HCG's 52-week high and low?

Over the last 52 weeks to 30 Oct 2026, HCG traded between ₹513.30 and ₹804.65.

Sector: [Healthcare](https://trinetra.trade/sectors/healthcare) · Page: https://trinetra.trade/fundamentals/HCG

_TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing._